News: Portfolio 2005

PA Early Stage Makes Series A Investment in Cellumen

(continued)

 

About Cellumen

Cellumen is a systems cell biology company that is focused on defining the functions of genes, coding and non-coding RNA's, proteins and other cellular constituents that regulate and perform the myriad of functions that define normal life and are related to specific disease processes as potential biomarkers and/or targets for drug discovery and patient profiling. Cellumen uses multiple High Content Screening (HCS) platforms with a wide range of both commercially available and proprietary reagents to create multiplexed assays to define pathways, identify potential molecular biomarkers of disease, perform screens and to explore applications of HCS and molecular imaging for the whole process of drug discovery from target ID through clinical trial support. Cellumen can be found on the internet at www.cellumen.com

 

 

 

 

About PA Early Stage Partners

PA Early Stage Partners, headquartered in Wayne, Pennsylvania and founded in 1997, is a family of venture funds that makes investment in early stage life sciences and technology companies. With over $235 million under management, PA Early Stage invests in companies that are primarily based in the Mid-Atlantic region, with a focus on Pennsylvania. The Fund can be found on the internet at www.paearlystage.com.

 

Page: 1 2 4